Donald Sutherland

TL;DR: The WHO HIVDR threshold survey method is feasible in resource-limited countries and produces information relevant to ART and drug resistance prevention planning and the main challenges in implementation are acquiring sufficient numbers of eligible specimens and optimizing specimen handling.

TL;DR: The World Health Organization (WHO) recommends a minimum-resource strategy for prevention and assessment of HIVDR in resource-limited countries, which should limit HIV drug resistance if programme effectiveness continues during scale-up.

TL;DR: The WHO has developed a population-based HIVDR assessment and prevention strategy, which includes standardized HIVDR monitoring surveys in populations receiving first-line ART at sentinel sites, which will inform evidence-based decision making regarding national and global ART regimen selection and minimize the emergence of HIVDR at a population level.

TL;DR: Genotyping of 50 consecutive specimens each from blood donors and VCT clients during 2005-2006 showed no mutations associated with HIVDR in the reverse transcriptase or protease regions of the HIV pol gene, representing a low prevalence (<5%) of transmitted HIV drug resistance.

TL;DR: The World Health Organization (WHO) in collaboration with international experts has developed a laboratory strategy, which has the overall goal of delivering quality-assured HIV genotypic results on specimens derived from the HIVDR surveys, to help control the emergence and spread of drug resistance.